All In Biotech

Drug Trial Radar · NCT00464308

A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg

The Rabeprazole and Esomeprazole Reflux Assessment Trial (TREAT)

Last checked: Nov 20, 2026Latest source record: Apr 21, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 1,392 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,392

Actual

Start

Nov 2006

Primary completion

May 2008

Study completion May 2008

Sponsor

Lead sponsor
Janssen-Cilag Pty LtdJohnson & Johnson (Janssen) (JNJ)
Sponsor type
Industry
First posted
Apr 23, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to compare, the number of patients with heartburn and regurgitation symptom resolution after treatment with either rabeprazole 20 mg, esomeprazole 20 mg or esomeprazole 40 mg.

Conditions

  • Gastro-oesophageal Reflux

Interventions

  • EsomeprazoleDrug

    20mg once daily for 28days - 1 placebo tab/cap \& 1 active tab/cap daily

  • RabeprazoleDrug

    20mg once daily for 28days - 1 placebo tab/cap \& 1 active tab/cap daily

  • EsomeprazoleDrug

    40mg once daily for 28days - 1 placebo tab/cap \& 1 active tab/cap daily

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The Number of Patients With Complete Resolution of Heartburn by Week 4Time frame: week 4 of treatment
  2. The Number of Patients Achieving Complete Resolution of Regurgitation Symptoms at Week 4Time frame: 4 weeks
  3. The Number of Patients Achieving Satisfactory Resolution of Heartburn by Week 4Time frame: 4 weeks
  4. The Number of Patients Achieving Satisfactory Resolution of Regurgitation Symptoms by Week 4Time frame: 4 weeks

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Belconnen, Australia

  • Site not named

    Bondi Junction, Australia

  • Site not named

    Brookvale, Australia

  • Site not named

    Browns Plains, Australia

  • Site not named

    Campbelltown, Australia

  • Site not named

    Campsie, Australia

  • Site not named

    Caringbah, Australia

  • Site not named

    Castle Hill, Australia

  • Site not named

    Charlestown, Australia

  • Site not named

    Dapto, Australia

  • Site not named

    Darlinghurst, Australia

  • Site not named

    Dubbo, Australia

  • Site not named

    Elizabeth, Australia

  • Site not named

    Fairfield, Australia

  • Site not named

    Hoppers Crossing, Australia

  • Site not named

    Ingleburn, Australia

  • Site not named

    Leichhardt, Australia

  • Site not named

    Maroubra, Australia

  • Site not named

    Melton, Australia

  • Site not named

    Mount Druitt, Australia

  • Site not named

    Oaklands Park, Australia

  • Site not named

    Royal Park, Australia

  • Site not named

    Sydney, Australia

  • Site not named

    Wentworthville, Australia

  • Site not named

    Wyoming, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.